Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-κB activation

Keyphrases

• Matrix metalloproteinase-9 (MMP-9) 100%
• NF-B 100%
• Intestinal Epithelial Cells 100%
• Endothelial Junctions 100%
• Tight Junction Barrier 100%
• Inflammatory Bowel Disease 36%
• Caco-2 36%
• Tight Junction 18%
• Barrier Function 18%
• Myosin Light Chain Kinase 18%
• Intestinal Permeability 18%
• Matrix Effect 9%
• Inflammation 9%
• Pathogenic Factors 9%
• Molecular Mechanism 9%
• Knockdown 9%
• Protein Expression 9%
• Necrosis 9%
• Apoptosis 9%
• Kinase Protein 9%
• Intracellular Signaling 9%
• Interleukin-8 9%
• Induced Expression 9%
• Nuclear Translocation 9%
• In Vitro Model 9%
• Stool 9%
• Intestinal Tissue 9%
• Tissue Damage 9%
• Pathway Activation 9%
• Intestinal Inflammation 9%
• Intestinal Tight Junction 9%
• Caco-2 Cell Monolayer 9%
• Intestinal Barrier Function 9%

Biochemistry, Genetics and Molecular Biology

• Gelatinase B 100%
• MMP9 100%
• Myosin Light-Chain Kinase 18%
• Protein Expression 9%
• Transfection 9%
• Small Interfering RNA 9%
• Interleukin 8 9%
• Intestinal Mucosal Barrier 9%
• Programmed Cell Death 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Gelatinase B 100%
• Inflammatory Bowel Disease 36%
• Intestinal Permeability 18%
• Myosin Light Chain Kinase 18%
• Inflammation 9%
• Necrosis 9%
• Tissue Injury 9%
• Small Interfering RNA 9%
• Enteritis 9%